EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Salvage HLA-haploidentical Peripheral Blood Stem Cell Transplantation Using Post-transplant Cyclophosphamide for Recurrent Hemophagocytic Lymphohistiocytosis-associated Graft Failure after Cord Blood Transplantations

Keijiro Sato, Wataru Komaba, Saika Oka, Shintaro Kazama, Ryuto Ishikawa, Takahiro Morikawa, Mari Kitahara, Hiroko Kazumoto, Hiroko Kaiume, Toshimitsu Ueki, Yuki Hiroshima, Masahiko Sumi und 1 weitere

Internal Medicine · 2025

DOI: 10.2169/internalmedicine.5159-24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Internal Medicine, 2025. Verfasst von Keijiro Sato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nagano Red Cross Hospital, Japan. Hauptthemen laut MEDLINE: Cord Blood Stem Cell Transplantation, Cyclophosphamide, Graft Rejection, Lymphohistiocytosis, Hemophagocytic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a case of immunological rejection occurring twice after cord blood transplantation (CBT) for mixed phenotype blast phase chronic myeloid leukemia that was successfully salvaged by haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) with post-transplant cyclophosphamide (PT-Cy). Pre-engraftment immune reaction (PIR) and subsequent hemophagocytic lymphohistiocytosis (HLH), likely due to HLA mismatch in the graft-versus-host (GVH) direction, lead to poor graft function (PGF) and graft failure (GF). This case highlights the pathophysiology of PIR, HLH, PGF, and GF, collectively termed "post-transplant cytokine syndrome." PT-Cy haplo-PBSCT, with wide donor availability and reduced infection risk leading to HLH via rapid engraftment, may be a suitable salvage option for post-CBT cytokine syndrome-related GF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cord Blood Stem Cell TransplantationCyclophosphamideGraft RejectionLymphohistiocytosis, HemophagocyticPeripheral Blood Stem Cell TransplantationSalvage TherapyFemaleHumansMaleGraft vs Host DiseaseHLA AntigensImmunosuppressive AgentsRecurrenceTransplantation, Haploidentical

Stichwörter der Autor:innen

HLA-haploidentical transplantationcord blood transplantationgraft failurehemophagocytic lymphohistiocytosispost-transplant cyclophosphamide

Substanzen

CyclophosphamideHLA AntigensImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Hematology, Nagano Red Cross Hospital, Japan.

Zitieren

APA

Sato, K., Komaba, W., Oka, S., Kazama, S., Ishikawa, R., Morikawa, T., Kitahara, M., Kazumoto, H., Kaiume, H., Ueki, T., Hiroshima, Y., Sumi, M., & Kobayashi, H. (2025). Salvage HLA-haploidentical Peripheral Blood Stem Cell Transplantation Using Post-transplant Cyclophosphamide for Recurrent Hemophagocytic Lymphohistiocytosis-associated Graft Failure after Cord Blood Transplantations. Internal Medicine. https://doi.org/10.2169/internalmedicine.5159-24

Vancouver

Sato K, Komaba W, Oka S, Kazama S, Ishikawa R, Morikawa T, et al. Salvage HLA-haploidentical Peripheral Blood Stem Cell Transplantation Using Post-transplant Cyclophosphamide for Recurrent Hemophagocytic Lymphohistiocytosis-associated Graft Failure after Cord Blood Transplantations. Internal Medicine. 2025. doi:10.2169/internalmedicine.5159-24

BibTeX
@article{Sato2025,
  author = {Sato, Keijiro and Komaba, Wataru and Oka, Saika and Kazama, Shintaro and Ishikawa, Ryuto and Morikawa, Takahiro and Kitahara, Mari and Kazumoto, Hiroko and Kaiume, Hiroko and Ueki, Toshimitsu and Hiroshima, Yuki and Sumi, Masahiko and Kobayashi, Hikaru},
  title = {Salvage HLA-haploidentical Peripheral Blood Stem Cell Transplantation Using Post-transplant Cyclophosphamide for Recurrent Hemophagocytic Lymphohistiocytosis-associated Graft Failure after Cord Blood Transplantations},
  journal = {Internal Medicine},
  year = {2025},
  doi = {10.2169/internalmedicine.5159-24}
}
Kostenlos starten →